MetLife Investment Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

MetLife Investment Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,381	Closed	-$1.49M	–	2365
2019 Q3	$1.49M	Hold	15,381	–	–	0.02%	896
2019 Q2	$1.57M	Buy	15,381 +927	+6%	+$100K	0.02%	915
2019 Q1	$1.65M	Hold	14,454	–	–	0.02%	892
2018 Q4	$566K	Hold	14,454	–	–	0.01%	1289
2018 Q3	$788K	Hold	14,454	–	–	0.01%	1253
2018 Q2	$1.2M	Buy	14,454 +1,869	+15%	+$144K	0.01%	953
2018 Q1	$838K	Hold	12,585	–	–	0.01%	1085
2017 Q4	$647K	Buy	+12,585	New	+$904K	0.01%	1252

MetLife Investment Management's ONCE Position: Q4 2019 in Review

MetLife Investment Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 15,381 shares — an estimated $1.49M sold.

MetLife Investment Management first reported a position in ONCE in Q4 2017 and held it in 8 quarters. The position peaked at $1.65M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

MetLife Investment Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
MetLife Investment Management sold 15,381 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $1.49M.
MetLife Investment Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
MetLife Investment Management's Spark Therapeutics, Inc. Common Stock position peaked at $1.65M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.